相关实验视频
Updated: Jul 12, 2025

05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.7K
设计,对接,表征和合成用于抗抑郁药活性的胺衍生物
Ashwini Jadhav1, Sunil G Shingade1, Prachita G Dessai1
1Department of Pharmaceutical Chemistry, PES's Rajaram and Tarabai Bandekar College of Pharmacy, Ponda, Goa, 403 401, India.
Current drug discovery technologies
|October 20, 2023
概括
研究人员合成了新的胺衍生物作为潜在的抗抑郁药物. 化合物24显示出最高的分子对接得分和强大的体内抗抑郁药活性,显示出治疗抑郁症的前景.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药物发现 药物发现 药物发现
背景情况:
- 印度的抑郁症患病率很高,需要新的治疗药物.
- 皮里米丁衍生物已经显示出潜在的抗抑郁作用.
- 这项研究的重点是为抗抑郁药应用合成新型金胺衍生物.
研究的目的:
- 为了合成和表征2 - - - - - - - - - - - - - - - - - - - - - - - 4 - - - - 二二二烯基胺-2-) 氧) - - - - - - - - - 乙烯酸衍生物.
- 评估这些新型化合物的体内抗抑郁活性.
- 执行分子对接,以预测结合亲和力.
主要方法:
- 复合物被设计并使用Molegro虚拟Docker (MVD) 进行虚拟选.
- 一系列的胺衍生物 (17-26) 通过多步反应合成.
- 合成的化合物使用光谱分析进行了表征,并评估了体内抗抑郁药物的活性.
主要成果:
- 所有合成的衍生品与克洛米普拉胺相比,都表现出与人体血清素载体的更高的结合亲和力.
- 复合体24显示了最高的MolDock得分 (-182.095).
- 化合物24表现出最强的抗抑郁药活性,显著减少不运动时间,其次是化合物20.
结论:
- 化合物24被确定为一种新型抗抑郁药剂的非常有前途的候选者.
- 合成的胺衍生物显示出对抑郁症治疗的显著潜力.
- 需要进一步的研究来探索这些化合物的治疗潜力.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
254
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
254
Antidepressant Drugs: Overview
524
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
524
Structure-Activity Relationships and Drug Design
735
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
735
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
410
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
410
Drug Discovery: Overview
8.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.0K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.1K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.1K

